CAPTRUST Financial Advisors’s Amicus Therapeutics FOLD Stock Holding History

CAPTRUST Financial Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,335	Closed	-$222K	–	3323
2026 Q1	$222K	Sell	15,335 -10,065	-40%	-$144K	﹤0.01%	2613
2025 Q4	$362K	Buy	25,400 +460	+2%	+$4.52K	﹤0.01%	2110
2025 Q3	$197K	Buy	+24,940	New	+$177K	﹤0.01%	2435
2022 Q3	–	Sell	-248	Closed	-$3K	–	2771
2022 Q2	$3K	Sell	248 -538	-68%	-$4.43K	﹤0.01%	4293
2022 Q1	$7K	Buy	786 +577	+276%	+$5.41K	﹤0.01%	3959
2021 Q4	$2K	Hold	209	–	–	﹤0.01%	4403
2021 Q3	$2K	Buy	209 +30	+17%	+$307	﹤0.01%	4252
2021 Q2	$2K	Sell	179 -110	-38%	-$1.07K	﹤0.01%	4164
2021 Q1	$3K	Buy	+289	New	+$4.47K	﹤0.01%	3910

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

CAPTRUST Financial Advisors's FOLD Position: Q2 2026 in Review

CAPTRUST Financial Advisors sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 15,335 shares — an estimated $222K sold.

CAPTRUST Financial Advisors first reported a position in FOLD in Q1 2021 and held it in 9 quarters. The position peaked at $362K in Q4 2025. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

CAPTRUST Financial Advisors reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
CAPTRUST Financial Advisors sold 15,335 Amicus Therapeutics shares in Q2 2026, an estimated $222K.
CAPTRUST Financial Advisors first reported a position in Amicus Therapeutics in Q1 2021 and held it in 9 quarters.
CAPTRUST Financial Advisors's Amicus Therapeutics position peaked at $362K in Q4 2025.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.